Breaking News Instant updates and real-time market news.

2022-01-26 04:55:00 04:55 01/26/22 01/26 04:55 01/26/22 04:55	Goldman Sachs to hold a virtual conference Virtual Global Macro Conference Asia Pacific 2022 to be held on January 25-26. Webcast Link

2022-01-26 04:55:00

04:55

01/26/22

01/26

04:55

01/26/22

04:55

Goldman Sachs to hold a virtual conference

Virtual Global Macro Conference Asia Pacific 2022 to be held on January 25-26. Webcast Link

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Latch workforce redaction a net positive, says William Blair » 07:32 05/23/22 05/23 07:32 05/23/22 07:32 LTCH Latch $2.20 / -0.005 (-0.23%) William Blair analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options LTCH Latch $2.20 / -0.005 (-0.23%) 05/20/22 Latch announces reset of cost structure 03/29/22 Latch CFO Mitchell to resign, appoint Schaeffer as interim CFO, Nakamura as CAO LTCH Latch $2.20 / -0.005 (-0.23%) 02/28/22 Imperial Capital Latch downgraded to In-Line from Outperform at Imperial Capital 02/28/22 Baird Latch price target lowered to $4 from $8 at Baird 02/25/22 Cantor Fitzgerald Latch downgraded to Neutral from Overweight at Cantor Fitzgerald 02/14/22 Keefe Bruyette Latch initiated with a Market Perform at Keefe Bruyette LTCH Latch $2.20 / -0.005 (-0.23%) 05/05/22 Latch Sees FY22 revenue $75M-$100M, consensus $86.62M. 05/05/22 Latch sees Q2 revenue $16.5M-$18.5M, consensus $18.06M 05/05/22 Latch reports Q1 EPS (31c), consensus (32c) 02/24/22 Latch reports Q4 net loss 53,908 vs. 19,193 loss in Q420 LTCH Latch $2.20 / -0.005 (-0.23%) 02/25/22 What You Missed On Wall Street On Friday 02/25/22 What You Missed On Wall Street This Morning 06/09/22 Latch Inc LTCH Latch $2.20 / -0.005 (-0.23%) 02/24/22 Latch options imply 16.2% move in share price post-earnings
Hot Stocks	Concert Pharmaceuticals trading resumes 07:32 05/23/22 05/23 07:32 05/23/22 07:32 CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) ShowHide Related Items >><< Company News Street Research Earnings Events CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 07:32 Today Concert Pharmaceuticals trading halted, news pending 07:20 Today Concert :THRIVE-AA1 study meets primary endpoint for scalp hair regrowth 01/04/22 Concert Pharmaceuticals completes enrollment in THRIVE-AA2 trial CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 11/12/21 JMP Securities Concert Pharmaceuticals price target lowered to $10 from $17 at JMP Securities 10/05/21 Mizuho Concert Pharmaceuticals price target lowered to $9 from $13 at Mizuho CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 05/05/22 Concert Pharmaceuticals reports Q1 EPS ($1.03), consensus (91c) 03/03/22 Concert Pharmaceuticals reports Q4 EPS ($1.01), consensus (73c) 06/09/22 Concert Pharmaceuticals, Inc.
Hot Stocks	Concert Pharmaceuticals trading halted, news pending 07:32 05/23/22 05/23 07:32 05/23/22 07:32 CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) ShowHide Related Items >><< Company News Street Research Earnings Events CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 07:20 Today Concert :THRIVE-AA1 study meets primary endpoint for scalp hair regrowth 01/04/22 Concert Pharmaceuticals completes enrollment in THRIVE-AA2 trial CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 11/12/21 JMP Securities Concert Pharmaceuticals price target lowered to $10 from $17 at JMP Securities 10/05/21 Mizuho Concert Pharmaceuticals price target lowered to $9 from $13 at Mizuho CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 05/05/22 Concert Pharmaceuticals reports Q1 EPS ($1.03), consensus (91c) 03/03/22 Concert Pharmaceuticals reports Q4 EPS ($1.01), consensus (73c) 06/09/22 Concert Pharmaceuticals, Inc.
Hot Stocks	Biohaven Pharmaceutical: FDA accepts for review NDA for zavegepant nasal spray » 07:32 05/23/22 05/23 07:32 05/23/22 07:32 BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) Biohaven Pharmaceutical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 07:19 Today Biohaven Pharmaceutical provides update on Phase 3 troriluzole trial in SCA 05/10/22 Biohaven Pharmaceutical rises 70.2% 05/10/22 Biohaven Pharmaceutical rises 70.8% 05/10/22 Biohaven Pharmaceutical rises 70.7% BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/11/22 H.C. Wainwright Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright 05/11/22 Wedbush Global Blood Therapeutics added to Best Ideas List at Wedbush 05/02/22 Piper Sandler Piper sees 'outright misinformation' on Biohaven, says buy shares 04/22/22 Piper Sandler Biohaven widening lead over AbbVie in migraine, says Piper Sandler BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 Biohaven Pharmaceutical sees 2022 net product sales $825M-$900M 05/10/22 Biohaven Pharmaceutical reports Q1 EPS ($2.97), consensus ($2.53) 02/25/22 Biohaven Pharmaceutical reports Q4 adjusted EPS ($2.32), consensus ($2.04) BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 01/13/22 Biogen working with Goldman to explore possible acquisitions, STAT says BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning 05/10/22 Fly Intel: Pre-market Movers 01/13/22 Wall Street in Fives - Must Read Lists for Thursday
Hot Stocks	Immunocore and Medison Pharma extend multi-territorial agreement for Kimmtrak » 07:29 05/23/22 05/23 07:29 05/23/22 07:29 IMCR Immunocore $30.25 / +1.13 (+3.88%) Immunocore announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings IMCR Immunocore $30.25 / +1.13 (+3.88%) 04/04/22 Immunocore announces EC approval of KIMMTRAK 02/25/22 Immunocore announces CHMP opinion recommending approval of Kimmtrak 01/26/22 Immunocore announces FDA approval of KIMMTRAK 12/06/21 Immunocore announces initial Phase 1 data from IMC-C103C IMCR Immunocore $30.25 / +1.13 (+3.88%) 02/08/22 H.C. Wainwright Immunocore initiated with a Buy at H.C. Wainwright 11/11/21 JPMorgan Immunocore share catalysts are 'picking up,' says JPMorgan 10/19/21 Oppenheimer Immunocore initiated with an Outperform at Oppenheimer IMCR Immunocore $30.25 / +1.13 (+3.88%) 05/11/22 Immunocore reports Q1 EPS EUR 37 vs. EUR 76 last year 03/03/22 Immunocore reports Q4 EPS ($1.21), three estimates (1.10)

Initiation	Applied Blockchain initiated with a Buy at Craig-Hallum » 07:28 05/23/22 05/23 07:28 05/23/22 07:28 APLD Applied Blockchain / + Craig-Hallum analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events APLD Applied Blockchain / + 05/10/22 Applied Blockchain expands blockchain industry infrastructure 04/13/22 Applied Blockchain prices $40M initial public offering APLD Applied Blockchain / + 05/09/22 Lake Street Applied Blockchain initiated with a Buy at Lake Street 05/09/22 Northland Applied Blockchain initiated with an Outperform at Northland 05/09/22 B. Riley Applied Blockchain initiated with a Buy at B. Riley 05/09/22 Needham Applied Blockchain initiated with a Buy at Needham 13 Apr APLD Applied Blockchain / + 05/09/22 What You Missed On Wall Street On Monday 05/09/22 What You Missed On Wall Street This Morning 05/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/07/22 Opening Day: Bausch + Lomb pops in public debut 05/25/22 22nd Annual Institutional Investor Conference
Upgrade	Wesdome Gold Mines upgraded to Buy from Hold at Canaccord » 07:28 05/23/22 05/23 07:28 05/23/22 07:28 WDOFF Wesdome Gold Mines $9.56 / +0.114 (+1.21%) Canaccord analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research WDOFF Wesdome Gold Mines $9.56 / +0.114 (+1.21%) 05/05/22 Wesdome Gold Mines announces drilling results from Eagle River Mine 04/14/22 Wesdome Gold Mines reports Q1 gold production of 25,611 oz 02/08/22 Wesdome Gold Mines announces results from Kiena Deep A Zone 01/13/22 Wesdome Gold Mines sees 2022 production 160,000-180,000 ounces WDOFF Wesdome Gold Mines $9.56 / +0.114 (+1.21%) 05/12/22 TD Securities Wesdome Gold Mines price target lowered to C$19 from C$20 at TD Securities 04/20/22 National Bank Wesdome Gold Mines price target raised to C$19 from C$18.75 at National Bank 04/07/22 RBC Capital Wesdome Gold Mines initiated with a Sector Perform at RBC Capital 03/14/22 TD Securities Wesdome Gold Mines price target raised to C$17.50 from C$15.50 at TD Securities
Upgrade	Kainos Group upgraded to Buy from Hold at Canaccord » 07:27 05/23/22 05/23 07:27 05/23/22 07:27 KNNNF Kainos Group $25.55 / + (+0.00%) Canaccord analyst Kai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KNNNF Kainos Group $25.55 / + (+0.00%) 05/16/22 Berenberg Kainos Group downgraded to Hold from Buy at Berenberg 11/15/21 Canaccord Kainos Group price target raised to 1,880 GBp from 1,765 GBp at Canaccord
Upgrade	Argonaut Gold upgraded to Hold from Sell at Canaccord » 07:27 05/23/22 05/23 07:27 05/23/22 07:27 ARNGF Argonaut Gold $1.13 / +0.09522 (+9.20%) Canaccord analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ARNGF Argonaut Gold $1.13 / +0.09522 (+9.20%) 05/16/22 Desjardins Argonaut Gold price target lowered to C$2.50 from C$3.25 at Desjardins 05/12/22 Scotiabank Argonaut Gold price target lowered to C$3 from C$3.50 at Scotiabank 05/12/22 Canaccord Argonaut Gold downgraded to Sell from Hold at Canaccord 04/19/22 Scotiabank Argonaut Gold price target raised to C$3.50 from C$3.25 at Scotiabank
Recommendations	Deal for VMware would be synergistic with Broadcom strategy, says BofA » 07:23 05/23/22 05/23 07:23 05/23/22 07:23 AVGO Broadcom $544.19 / -1.72 (-0.32%) , VMW VMware $95.71 / +0.76 (+0.80%) BofA analyst Vivek Arya… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 05/22/22 Fly Intel: Top five weekend stock stories 05/06/22 TD Synnex secures cybersecurity aggregator agreement with Broadcom 05/03/22 Broadcom announces opportunities for solutions with Z16 Mainframe 04/24/22 Fly Intel: Top five weekend stock stories VMW VMware $95.71 / +0.76 (+0.80%) 05/22/22 Fly Intel: Top five weekend stock stories 05/04/22 VMware, Wipro expand partnership for customers' digital transformation 04/06/22 VMware and Deloitte to launch strategic Distributed Cloud Practice 04/05/22 VMware CFO sells $3.9M in common stock AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 06:13 Today Piper Sandler VMware passes Broadcom deal 'smell-test,' says Piper Sandler 05/20/22 Daiwa Daiwa sees six month 'danger zone' for semiconductor stocks 05/17/22 Piper Sandler Piper moves to 'more positive stance' on semiconductor stocks 04/14/22 Credit Suisse TSMC results may give 'tactical reprieve' to U.S. Semis, says Credit Suisse VMW VMware $95.71 / +0.76 (+0.80%) 06:13 Today Piper Sandler VMware passes Broadcom deal 'smell-test,' says Piper Sandler 05/18/22 Mizuho VMware price target lowered to $115 from $125 at Mizuho 02/25/22 Barclays VMware price target lowered to $135 from $140 at Barclays 02/25/22 Oppenheimer VMware price target lowered to $135 from $148 at Oppenheimer AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 03/03/22 Broadcom sees Q2 revenue $7.9B, consensus $7.43B 03/03/22 Broadcom reports Q1 adjusted EPS $8.39, consensus $8.08 03/03/22 Notable companies reporting after market close 12/09/21 Broadcom sees Q1 revenue $7.6B, consensus $7.25B VMW VMware $95.71 / +0.76 (+0.80%) 02/24/22 VMware sees FY23 EPS $6.97, consensus $7.29 02/24/22 VMware sees Q1 EPS $1.56, consensus $1.64 02/24/22 VMware reports Q4 adjusted EPS $2.02, consensus $1.97 02/24/22 Notable companies reporting after market close AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 05/22/22 Broadcom in talks to acquire VMware, Reuters reports 04/23/22 Merck, CVS among dividend stocks to help whip inflation now, Barron's says 04/22/22 Broadcom once again in FTC crosshairs over antitrust, Information says 03/05/22 Cloud stocks have become a haven in tech, Barron's says VMW VMware $95.71 / +0.76 (+0.80%) 05/22/22 Broadcom in talks to acquire VMware, Reuters reports 04/13/22 Hackers exploiting VMware servers, Bleeping Computer says AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 03/04/22 What You Missed On Wall Street On Friday 03/04/22 What You Missed On Wall Street This Morning 03/03/22 Fly Intel: After-Hours Movers 12/27/21 Fly Insider: Hyatt, Alnylam among week's notable insider trades VMW VMware $95.71 / +0.76 (+0.80%) 02/25/22 What You Missed On Wall Street On Friday 02/25/22 What You Missed On Wall Street This Morning 02/25/22 Fly Intel: Pre-market Movers 02/24/22 Fly Intel: After-Hours Movers 05/27/22 Technology 05/26/22 VMware - VMW 06/02/22 Broadcom - AVGO AVGO VMW AVGO Broadcom $544.19 / -1.72 (-0.32%) 12/14/21 Broadcom put volume heavy and directionally bearish 12/10/21 Early notable gainers among liquid option names on December 10th 12/09/21 Broadcom options imply 3.2% move in share price post-earnings VMW VMware $95.71 / +0.76 (+0.80%) 12/02/21 VMware call volume above normal and directionally bullish 11/23/21 VMware options imply 4.8% move in share price post-earnings

Hot Stocks	Secoo receives withdrawal of Richard Rixue Li's going private proposal » 07:21 05/23/22 05/23 07:21 05/23/22 07:21 SECO Secoo Holding / + Secoo Holding announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News SECO Secoo Holding / + 04/19/22 Secoo announces changes to board composition 04/07/22 Secoo Holding, ZiWu announce NFT cooperation
Hot Stocks	Concert :THRIVE-AA1 study meets primary endpoint for scalp hair regrowth » 07:20 05/23/22 05/23 07:20 05/23/22 07:20 CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) Concert Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 01/04/22 Concert Pharmaceuticals completes enrollment in THRIVE-AA2 trial CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 11/12/21 JMP Securities Concert Pharmaceuticals price target lowered to $10 from $17 at JMP Securities 10/05/21 Mizuho Concert Pharmaceuticals price target lowered to $9 from $13 at Mizuho CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 05/05/22 Concert Pharmaceuticals reports Q1 EPS ($1.03), consensus (91c) 03/03/22 Concert Pharmaceuticals reports Q4 EPS ($1.01), consensus (73c) 06/09/22 Concert Pharmaceuticals, Inc.
Hot Stocks	Jaguar Health announces launch of U.S. Canine Cancer Registry » 07:20 05/23/22 05/23 07:20 05/23/22 07:20 JAGX Jaguar Health / + Jaguar Health, announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options JAGX Jaguar Health / + 05/11/22 Jaguar Health announces launch of Mytesi telehealth program 05/03/22 Jaguar Health files for conditional new animal drug approval of Canalevia 04/27/22 Jaguar Health announces commercial availability of Canalevia-CA1 04/05/22 Jaguar Health appoints Pravin Chaturvedi as CSO, chair of SAB JAGX Jaguar Health / + 07/07/21 Fly Intel: Top five analyst initiations 07/07/21 Cantor Fitzgerald Jaguar Health initiated with an Overweight at Cantor Fitzgerald JAGX Jaguar Health / + 05/10/22 Jaguar Health reports Q1 EPS (40c) vs. (28c) last year 06/10/22 Jaguar Health Inc. JAGX Jaguar Health / + 01/14/22 Largest borrow rate increases among liquid names
Hot Stocks	Biohaven Pharmaceutical provides update on Phase 3 troriluzole trial in SCA » 07:19 05/23/22 05/23 07:19 05/23/22 07:19 BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) Biohaven Pharmaceutical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 Biohaven Pharmaceutical rises 70.2% 05/10/22 Biohaven Pharmaceutical rises 70.8% 05/10/22 Biohaven Pharmaceutical rises 70.7% 05/10/22 Pfizer to acquire Biohaven Pharmaceuticals for $148.50 per share BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/11/22 H.C. Wainwright Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright 05/11/22 Wedbush Global Blood Therapeutics added to Best Ideas List at Wedbush 05/02/22 Piper Sandler Piper sees 'outright misinformation' on Biohaven, says buy shares 04/22/22 Piper Sandler Biohaven widening lead over AbbVie in migraine, says Piper Sandler BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 Biohaven Pharmaceutical sees 2022 net product sales $825M-$900M 05/10/22 Biohaven Pharmaceutical reports Q1 EPS ($2.97), consensus ($2.53) 02/25/22 Biohaven Pharmaceutical reports Q4 adjusted EPS ($2.32), consensus ($2.04) BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 01/13/22 Biogen working with Goldman to explore possible acquisitions, STAT says BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning 05/10/22 Fly Intel: Pre-market Movers 01/13/22 Wall Street in Fives - Must Read Lists for Thursday
Hot Stocks	Kaman to acquire Parker-Hannifin aircraft wheel & brake division for $440M » 07:18 05/23/22 05/23 07:18 05/23/22 07:18 KAMN Kaman $32.87 / -0.725 (-2.16%) , PH Parker-Hannifin $258.80 / -4.05 (-1.54%) Kaman (KAMN) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 07:06 Today Parker-Hannifin to divest Aircraft Wheel, Brake Division to Kaman 05/02/22 Kaman maintains FY guidance 04/20/22 Kaman announces $50M share repurchase program 03/07/22 Kaman gets follow-up award for HH-60W combat rescue helicopter cockpits PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 07:06 Today Parker-Hannifin to divest Aircraft Wheel, Brake Division to Kaman 04/28/22 Parker-Hannifin increases quarterly cash dividend 29% to $1.33 per share 04/11/22 Parker-Hannifin says European Commission clears acquisition of Meggitt 04/05/22 Parker-Hannifin says third party gained unauthorized access to company's systems KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 05/04/22 KeyBanc Kaman price target lowered to $45 from $52 at KeyBanc 02/28/22 KeyBanc Kaman price target lowered to $52 from $59 at KeyBanc 06/23/21 KeyBanc Kaman price target lowered to $59 from $65 at KeyBanc PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 05/06/22 Mizuho Parker-Hannifin price target lowered to $290 from $305 at Mizuho 04/18/22 Stifel Parker-Hannifin price target lowered to $338 from $384 at Stifel 04/14/22 Deutsche Bank Parker-Hannifin price target lowered to $335 from $343 at Deutsche Bank 04/04/22 Barclays Parker-Hannifin price target lowered to $350 from $376 at Barclays KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 05/02/22 Kaman reports Q1 adjusted EPS 15c vs. 29c last year 02/24/22 Kaman reports Q4 adjusted EPS 48c, consensus 47c PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 05/05/22 Parker-Hannifin updates FY22 adjusted EPS view $18.00-$18.30 from $17.80-$18.30 05/05/22 Parker-Hannifin reports Q3 adjusted EPS $4.83, consensus $4.65 02/03/22 Parker-Hannifin raises FY22 adjusted EPS view $17.80-$18.30 from $16.95-$17.65 02/03/22 Parker-Hannifin reports Q2 adjusted EPS $4.46, consensus $3.91 PH PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 04/01/22 EU regulators set to clear Parker-Hannifin's bid for Meggitt, Reuters says 04/01/22 EU antitrust regulators to approve Parker-Hannifin bid for Meggitt, Reuters says KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 05/02/22 Fly Intel: After-Hours Movers PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 04/01/22 What You Missed On Wall Street On Friday 04/01/22 What You Missed On Wall Street This Morning

Hot Stocks	Parsons to acquire Xator Corporation in $343M transaction » 07:18 05/23/22 05/23 07:18 05/23/22 07:18 PSN Parsons $36.24 / +0.365 (+1.02%) Parsons Corporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PSN Parsons $36.24 / +0.365 (+1.02%) 05/18/22 Parsons announces Parsons X approach 04/22/22 Parsons releases 2022 ESG report 04/13/22 Parsons completes critical design review for directed energy system 03/31/22 Parsons to highlight space domain capabilities at Space Symposium PSN Parsons $36.24 / +0.365 (+1.02%) 04/22/22 Truist Parsons downgraded to Hold from Buy at Truist 03/17/22 Stifel Parsons resumed with a Buy at Stifel 03/11/22 BofA Parsons upgraded to Neutral from Underperform at BofA 03/11/22 BofA Parsons upgraded to Neutral from Underperform at BofA PSN Parsons $36.24 / +0.365 (+1.02%) 05/04/22 Parsons backs 2022 revenue view $3.7B-$3.9B, consensus $3.8B 05/04/22 Parsons reports Q1 adjusted EPS 40c, consensus 38c 02/23/22 Parsons sees 2022 revenue $3.7B-$3.9B, consensus $3.79B 02/23/22 Parsons reports Q4 adjusted EPS 55c, consensus 53c PSN Parsons $36.24 / +0.365 (+1.02%) 03/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/01/22 IT Services Summit 06/14/22 Aerospace, Defense & Airlines ESG Virtual Summit 08/08/22 7th Annual Wells Fargo FinTech & Technology Services Forum
Downgrade	Athersys downgraded to Underperform from Neutral at BofA » 07:17 05/23/22 05/23 07:17 05/23/22 07:17 ATHX Athersys / + BofA analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options ATHX Athersys / + 05/20/22 Athersys sinks after partner's stem-cell therapy study fails to meet endpoint 04/04/22 Athersys: Healios K.K. reports update on MultiStem programs in Japan 01/20/22 Athersys appoints Daniel Camardo as CEO 11/30/21 Athersys announces peer-reviewed publication of data from MUST-ARDS trial ATHX Athersys / + 07:13 Today BofA Correction: Athersys downgraded to Underperform from Neutral at BofA 11/19/21 BofA Athersys downgraded to Neutral from Buy at BofA (yesterday) ATHX Athersys / + 05/06/22 Athersys reports Q1 EPS (9c), consensus (10c) 03/15/22 Athersys reports Q4 EPS (9c), consensus (7c) 06/15/22 Athersys, Inc. ATHX Athersys / + 03/15/22 Athersys options imply 26.0% move in share price post-earnings 12/09/21 Largest borrow rate increases among liquid names 12/08/21 Largest borrow rate increases among liquid names 12/06/21 Largest borrow rate increases among liquid names
Recommendations	Compass Minerals price target lowered to $55 from $73 at Deutsche Bank » 07:17 05/23/22 05/23 07:17 05/23/22 07:17 CMP Compass Minerals $43.37 / -0.91 (-2.06%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/05/22 Compass Minerals sees FY22 adjusted EBITDA $170M-$200M 04/12/22 Compass Minerals gets maximum payment from sale of specialty plant unit 04/11/22 Compass Minerals provides Q2 snow data and salt segment sales update 02/01/22 Compass Minerals to replace Great Western in S&P 600 at open on 2/1 CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/11/22 CL King Compass Minerals price target lowered to $52 from $67 at CL King 04/18/22 BMO Capital Compass Minerals price target raised to $63 from $60 at BMO Capital 03/03/22 CL King Compass Minerals price target raised to $67 from $65 at CL King 02/10/22 JPMorgan Compass Minerals downgraded to Underweight from Neutral at JPMorgan CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/05/22 Compass Minerals reports Q2 adjusted EPS 33c, consensus 91c 02/08/22 Compass Minerals cuts FY22 adjusted EBITDA view to $200M-$235M 02/08/22 Compass Minerals reports Q1 adjusted EPS 38c, consensus 55c CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/05/22 Fly Intel: After-Hours Movers
Recommendations	Flowers Foods price target lowered to $26 from $27 at Deutsche Bank » 07:16 05/23/22 05/23 07:16 05/23/22 07:16 FLO Flowers Foods $26.52 / +1.34 (+5.32%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FLO Flowers Foods $26.52 / +1.34 (+5.32%) 02/18/22 Flowers Foods increases quarterly dividend 5% to 21c per share 12/17/21 Flowers Foods recalls certain Nature's Own Honey Wheat bread sold in six states FLO Flowers Foods $26.52 / +1.34 (+5.32%) 11/15/21 Truist Flowers Foods price target raised to $30 from $25 at Truist 05/25/21 Stephens Flowers Foods assumed with an Equal Weight at Stephens 05/24/21 Deutsche Bank Flowers Foods price target lowered to $24 from $25 at Deutsche Bank FLO Flowers Foods $26.52 / +1.34 (+5.32%) 05/19/22 Flowers Foods lowers FY22 adjusted EPS view to $1.20-$1.30 from $1.25-$1.35 05/19/22 Flowers Foods reports Q1 adjusted EPS 44c, consensus 39c 02/10/22 Flowers Foods sees FY22 adjusted EPS $1.25-$1.35, consensus $1.27 02/10/22 Flowers Foods reports Q4 adjusted EPS 20c, consensus 21c FLO Flowers Foods $26.52 / +1.34 (+5.32%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/26/22 Flowers Foods, Inc.
Hot Stocks	Idaho Strategic adds Lemhi Pass Thorium Project » 07:16 05/23/22 05/23 07:16 05/23/22 07:16 IDR Idaho Strategic $7.10 / +0.08 (+1.14%) Idaho Strategic Resources… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings IDR Idaho Strategic $7.10 / +0.08 (+1.14%) 05/12/22 Idaho Strategic announces addition of Lemhi Pass REE project in Idaho 04/07/22 Idaho Strategic announces high-grade intercepts from Klondike Zone 03/15/22 Idaho Strategic announces participation in IGEM Project IDR Idaho Strategic $7.10 / +0.08 (+1.14%) 03/31/22 Idaho Strategic reports 2021 gold concentrate revenue $7.6M vs. $5.67M last year

Recommendations	Foot Locker price target raised to $32 from $30 at Deutsche Bank » 07:16 05/23/22 05/23 07:16 05/23/22 07:16 FL Foot Locker $31.52 / +1.22 (+4.03%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FL Foot Locker $31.52 / +1.22 (+4.03%) 05/20/22 Foot Locker rises 9.5% 05/20/22 Foot Locker sees FY22 comparable sales down 8%-10% 05/05/22 Foot Locker, Adidas announce new long-term strategic partnership 03/24/22 Foot Locker targets net zero GHG emissions by 2050 or sooner FL Foot Locker $31.52 / +1.22 (+4.03%) 06:24 Today Baird Foot Locker price target raised to $32 from $30 05/16/22 Deutsche Bank Foot Locker price target lowered to $30 from $32 at Deutsche Bank 05/16/22 OTR Global Foot Locker downgraded to Mixed from Positive at OTR Global 03/28/22 Cowen Cowen cuts Foot Locker to Market Perform, more cautious following March data FL Foot Locker $31.52 / +1.22 (+4.03%) 05/20/22 Foot Locker backs FY22 EPS $4.25-$4.60, consensus $4.41 05/20/22 Foot Locker reports Q1 EPS $1.60, consensus $1.55 05/19/22 Notable companies reporting before tomorrow's open 05/19/22 Notable companies reporting before tomorrow's open FL Foot Locker $31.52 / +1.22 (+4.03%) 03/05/22 Foot Locker has gotten hit hard, stock looks like a buy, Barron's says 03/02/22 Fanatics valued at $27B in latest fundraising, WSJ reports FL Foot Locker $31.52 / +1.22 (+4.03%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 03/28/22 What You Missed On Wall Street On Monday 05/24/22 6th Annual Future of the Consumer: Sustainable Growth for a New Ecosystem 08/19/22 Foot Locker - FL FL Foot Locker $31.52 / +1.22 (+4.03%) 05/20/22 Unusually active option classes on open May 20th 04/20/22 Foot Locker call volume above normal and directionally bullish 03/04/22 Foot Locker put volume heavy and directionally bearish 02/23/22 Unusually active option classes on open February 23rd
Recommendations	Sinclair Broadcast price target lowered to $28 from $31 at Deutsche Bank » 07:15 05/23/22 05/23 07:15 05/23/22 07:15 SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) 05/11/22 Sinclair Broadcast names Ryan Moore CRO, SVP of digital sales and sports 05/04/22 Sinclair Broadcast sees FY22 capital expenditures $98M-$108M 04/21/22 Sinclair Broadcast to offer HDR content for Bally Sports networks in Q3 04/14/22 Sinclair Broadcast, Charter reach comprehensive distribution agreement SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) 05/05/22 Wells Fargo Wells Fargo upgrades Sinclair Broadcast to Overweight, raises target to $33 05/05/22 Wells Fargo Sinclair upgraded to Overweight from Equal Weight at Wells Fargo 04/26/22 EF Hutton Sinclair Broadcast initiated with a Buy at EF Hutton 04/19/22 Rosenblatt Sinclair Broadcast initiated with a Neutral at Rosenblatt SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) 05/04/22 Sinclair Broadcast sees Q2 revenue $828M-$847M, consensus $1.64B 05/04/22 Sinclair Broadcast reports Q1 EPS $35.39, consensus $1.07 04/11/22 Sinclair Broadcast backs Broadcast segment Media revenues view of $709M-$725M 02/23/22 Sinclair Broadcast sees Q1 revenue $1.52B-$1.54B, consensus $1.52B SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) 01/10/22 Sinclair nears deal to carry NBA games on streaming app, Bloomberg reports SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) 05/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/11/22 What You Missed On Wall Street On Monday 01/10/22 Wall Street in Fives - Must Read Lists for Monday 06/09/22 Sinclair Broadcast Group Inc.
Recommendations	Momentus named short-term buy idea at Deutsche Bank » 07:14 05/23/22 05/23 07:14 05/23/22 07:14 MNTS Momentus $2.91 / +0.11 (+3.94%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events Options MNTS Momentus $2.91 / +0.11 (+3.94%) 05/12/22 Momentus completes integration of Vigoride on SpaceX Falcon 9 05/05/22 Momentus completes all regulatory milestones for inaugural mission 04/29/22 Momentus receives FCC license for first flight 04/07/22 Momentus signs launch service agreements with SpaceX MNTS Momentus $2.91 / +0.11 (+3.94%) 05/11/22 Deutsche Bank Momentus price target lowered to $7 from $8 at Deutsche Bank 03/23/22 Deutsche Bank SpaceX decision 'clear positive' for Momentus, says Deutsche Bank 01/10/22 Deutsche Bank Momentus initiated with a Buy at Deutsche Bank MNTS Momentus $2.91 / +0.11 (+3.94%) 04/07/22 Fly Intel: Pre-market Movers 11/30/21 Fly Intel: After-Hours Movers 05/31/22 Momentus Inc MNTS Momentus $2.91 / +0.11 (+3.94%) 05/10/22 Momentus options imply 11.4% move in share price post-earnings 04/20/22 Largest borrow rate increases among liquid names 04/07/22 Unusually active option classes on open April 7th 12/16/21 Largest borrow rate increases among liquid names
Hot Stocks	Alnylam announces new results from 18-month analysis of HELIOS-A study » 07:14 05/23/22 05/23 07:14 05/23/22 07:14 ALNY Alnylam $132.40 / +2.98 (+2.30%) Alnylam announced new… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ALNY Alnylam $132.40 / +2.98 (+2.30%) 04/04/22 FDA extends review timeline for Alnylam's vutrisiran NDA to treat ATTR amyloidos 04/01/22 Alnylam up 3%, strength attributed to conference cancellation speculation 03/17/22 Alnylam files patent infringement suits against Pfizer and Moderna 03/07/22 ProQR Therapeutics appoint Maraganore as strategic advisor to supervisory board ALNY Alnylam $132.40 / +2.98 (+2.30%) 05/02/22 H.C. Wainwright Alnylam price target raised to $430 from $400 at H.C. Wainwright 04/29/22 Citi Alnylam price target lowered to $211 from $223 at Citi 04/25/22 Morgan Stanley Alnylam downgraded to Equal Weight from Overweight at Morgan Stanley 04/12/22 H.C. Wainwright Alnylam price target raised to $400 from $350 at H.C. Wainwright ALNY Alnylam $132.40 / +2.98 (+2.30%) 04/28/22 Alnylam reports Q1 EPS ($2.00), consensus ($1.84) 02/10/22 Alnylam reports Q4 EPS ($1.69), consensus ($1.54) 02/10/22 Alnylam reports Q4 EPS ($1.69), consensus ($1.54) 01/09/22 Alnylam sees preliminary FY21 combined product revenues $662M ALNY Alnylam $132.40 / +2.98 (+2.30%) 03/17/22 What You Missed On Wall Street On Thursday 03/17/22 What You Missed On Wall Street This Morning 01/21/22 Fly Intel: Pre-market Movers 12/27/21 Wall Street in Fives - Must Read Lists for Monday 07/14/22 Extended PDUFA Date for Vutrisiran 10/06/22 PDUFA Date for Oxlumo (Lumasiran)
Hot Stocks	Power Solutions introduces turbo charge air cooled 8.8-liter engine » 07:13 05/23/22 05/23 07:13 05/23/22 07:13 PSIX Power Solutions $2.00 / +0.45 (+29.03%) Power Solutions… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News PSIX Power Solutions $2.00 / +0.45 (+29.03%) 04/13/22 Power Solutions' 6.0-liter industrial mobile engine receives EPA certification 03/28/22 Power Solutions announces extension to credit agreement 03/08/22 Power Solutions, Baudouin enter into international distribution agreement 03/07/22 Power Solutions to showcase 8.8 liter Power Systm engine during show

Events

Earnings calls, analyst events, roadshows and more

XPEV
Today at 08:00

XPeng - XPEV Conference Calls
NIU
Today at 08:00

Niu Technologies - NIU Conference Calls
CAAS
Today at 08:00

China Automotive - CAAS Conference Calls
CSTE
Today at 08:00

Caesarstone Firm Sponsored Meetings

Virtual Meeting
JPM
Today at 08:00

JPMorgan Firm Sponsored Meetings

Virtual Meeting
Today at 08:30

Chicago Fed National Activity Index--3 Month Moving Average: April 2022 Government Event
Today at 08:30

Chicago Fed National Activity Index: April 2022 Government Event
RSLS
Today at 08:30

ReShape Lifesciences - RSLS Conference Calls
AVPT
Today at 09:00

AvePoint Firm Sponsored Meetings

Virtual Meeting
GILT
Today at 09:30

Gilat Satellite - GILT Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Goldman Sachs to hold a virtual conference

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access